Clinical-dosimetric analysis of measures of dysphagia including gastrostomy-tube dependence among head and neck cancer patients treated definitively by intensity-modulated radiotherapy with concurrent chemotherapy

January 2009
Radiation Oncology;2009, Vol. 4, p52
Academic Journal
No abstract available.


Related Articles

  • Comment by H. Christiansen and C.F. Hess on G. Studer et al. Locoregional Failure Analysis in Head-and-Neck Cancer Patients Treated with IMRT. Christiansen, Hans // Strahlentherapie und Onkologie;Aug2007, Vol. 183 Issue 8, p424 

    A letter to the editor is presented in response to the article "Locoregional Failure Analysis in Head-and-Neck Cancer Patients Treated with intensity-modulated radiotherapy (IMRT)," by Gabriela Studer.

  • The impact of early percutaneous endoscopic gastrostomy placement on treatment completeness and nutritional status in locally advanced head and neck cancer patients receiving chemoradiotherapy. Atasoy, Beste; Yonal, Oya; Demirel, Birsen; Dane, Faysal; Yilmaz, Yusuf; Kalayci, Cem; Abacioglu, Ufuk; Imeryuz, Nese // European Archives of Oto-Rhino-Laryngology;Jan2012, Vol. 269 Issue 1, p275 

    To investigate the impact of early insertion of percutaneous endoscopic gastrostomy-tube on nutritional status and completeness of concurrent chemotherapy in locally advanced head and neck cancer patients treated with chemoradiotherapy. Twenty-three patients were enrolled into this prospective...

  • Favourable impact of intensity-modulated radiation therapy on chronic dysphagia in patients with head and neck cancer. Aanand, A. K.; Chaundhoory, A. R.; Shukla, A.; Negi, P. S.; Sinha, S. N.; Babu, A. A. G.; Munjal, R. K.; Dewan, A. K.; Kumar, K.; Doval, D. C.; Vaid, A. K. // British Journal of Radiology;Nov2008, Vol. 81 Issue 971, p865 

    The aim of this study was to evaluate the impact of intensity-modulated radiation therapy (IMRT) on the incidence and severity of chronic dysphagia in patients with head and neck cancer. 62 evaluable patients with head and neck cancer who were treated with IMRT with or without concurrent...

  • Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial.  // Radiation Oncology;2012, Vol. 7 Issue 1, p57 

    The article focuses on a study on the analysis of the REACH trial of a combination of chemotherapy carboplatin/5-FU, the EGFR antibody cetuximab and the intensity-modulated radiation therapy (IMRT) in order to evaluate the efficacy and toxicity in the treatment of locally advanced squamous cell...

  • Image-guided radiotherapy for locally advanced head and neck cancer. Nguyen, Nam P.; Kratz, Sarah; Lemanski, Claire; Vock, Jacqueline; Vinh-Hung, Vincent; Gorobets, Olena; Chi, Alexander; Almeida, Fabio; Betz, Michael; Khan, Rihan; Godinez, Juan; Karlsson, Ulf; Ampil, Fred // Frontiers in Oncology;Jul2013, Vol. 3, p1 

    Treatment of locally advanced head and neck cancer remains a challenge because of the head and neck complex anatomy and the tumor invasion to the adjacent organs and/or metastases to the cervical nodes. Postoperative irradiation or concurrent chemoradiation may lead to damage of radiosensitive...

  • IMRT plus chemotherapy offers high locoregional control in advanced nasopharynqeal carcinoma. Leiser, Mark; Stiglich, Joan-Marie; Stott, Bob; Todak, Sasha // Hem/Onc Today;8/10/2013, Vol. 14 Issue 15, p48 

    The article presents the study conducted in China as of August 2013, which showed that the treatment with intensity-modulated radiotherapy and concurrent weekly chemotherapy enhanced xerostomia and dysphagia in patients with advanced nasopharyngeal carcinoma.

  • Swallowing dysfunction in cancer patients. Raber-Durlacher, Judith; Brennan, Mike; Verdonck-de Leeuw, Irma; Gibson, Rachel; Eilers, June; Waltimo, Tuomas; Bots, Casper; Michelet, Marisol; Sollecito, Thomas; Rouleau, Tanya; Sewnaik, Aniel; Bensadoun, Rene-Jean; Fliedner, Monica; Silverman, Sol; Spijkervet, Fred // Supportive Care in Cancer;Mar2012, Vol. 20 Issue 3, p433 

    Purpose: Dysphagia (swallowing dysfunction) is a debilitating, depressing, and potentially life-threatening complication in cancer patients that is likely underreported. The present paper is aimed to review relevant dysphagia literature between 1990 and 2010 with a focus on assessment tools,...

  • Xerostomia after radiotherapy. Tribius, S.; Sommer, J.; Prosch, C.; Bajrovic, A.; Muenscher, A.; Blessmann, M.; Kruell, A.; Petersen, C.; Todorovic, M.; Tennstedt, P. // Strahlentherapie und Onkologie;Mar2013, Vol. 189 Issue 3, p216 

    Purpose: Xerostomia is a debilitating side effect of radiotherapy in patients with head and neck cancer. We undertook a prospective study of the effect on xerostomia and outcomes of sparing one or both parotid glands during radiotherapy for patients with squamous cell carcinoma of the head and...

  • Concurrent radiochemotherapy in advanced hypopharyngeal cancer. Krstevska, Valentina; Stojkovski, Igor; Lukarski, Dusko // Radiation Oncology;2010, Vol. 5, p39 

    Background: Concurrent platinum-based radiochemotherapy has been recommended as a standard of care in patients with locally advanced squamous cell head and neck carcinomas. Unfortunately, there is a lack of level one evidence on best treatment approach for advanced hypopharyngeal cancer. This...

  • Parotid gland-recovery after radiotherapy in the head and neck region - 36 months follow-up of a prospective clinical study.  // Radiation Oncology;2011, Vol. 6 Issue 1, p125 

    The article reports on a study conducted to evaluate parotid gland-recovery potential after 3D-conformal-radiotherapy (3D-CRT) or intensity-modulated radiotherapy (IMRT) in the head and neck region. It states 117 patients with head and neck cancer were included in the clinical study and had...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics